Case Studies

At Avira Digital, we’re motivated by our client’s success. As a driving force for the business with technology innovations, our team members help clients achieve their goals every day. Explore our work to understand how we provide cloud-native technology solutions and integrated services that make a real difference for our business partners.

Transforming Integrated Evidence Planning with Evidence 360
1

Challenge

Organizations struggled with siloed, manual processes, outdated tools, and limited visibility into evidence generation—leading to inefficiencies, delays, and missed opportunities.
2

Solution

  • Tailored IEP modules aligned to planning needs
  • Seamless integration (Veeva, registries, publications, social insights)
  • Harmonized global processes with governance
  • Real-time dashboards, KBQ reports, and analytics
  • Structured change management and training
    • 3

    Results

  • 26 IEPs digitized in one org; 12 in another with 10 more requested
  • 18+ KBQ and 14 visibility reports produced
  • 500–2,000 global users onboarded across 6+ TAs
  • Legacy process replaced in <6 months across 80+ markets and 500+ brands
  • ~20,000 hours saved in year one; 35% headcount reduction upfront
  • 40% efficiency gains, ~200 automation opportunities
  • ~20% TCO savings over 3 years
    • 1

    Business Challenge

    A leading global pharma company needed to evaluate perceptions of bispecific antibodies (bsAbs) versus CAR T-cell therapies in the second-line (2L) LBCL setting.

    Key challenges included:

  • bsAbs were EU-approved but not yet in the U.S.
  • Lack of sufficient internal or real-world clinical data.
  • Need to prepare strategically for a potential U.S. launch.
  • Social media identified as a critical source for real-time sentiment, awareness trends, and unmet needs from HCPs and patients.
    • 2

    Our Approach with Insight 360

    Insight 360 applied an AI-driven framework to uncover deep, actionable insights:

  • Curated Data: Pulled conversations from 11+ platforms, including social media and medical forums.
  • User Classification: Segmented HCPs, patients, and digital opinion leaders (DOLs).
  • Topic Modeling: Identified recurring themes, concerns, and evidence gaps.
  • Sentiment Scoring: Analyzed polarity and intensity of opinions.
  • Scientific Integration: Linked findings to publications, trials, and regulatory context.
    • 3

    Key Findings

  • Extracted 2.3K+ high-quality posts reflecting sentiment and clinical commentary.
  • Identified 500+ HCPs with differentiated views on bsAbs vs. CAR T.
  • Mapped previously untargeted DOLs active in the conversation.
  • Uncovered a critical awareness gap on curability and cost, signaling the need for targeted education.
    • 4

    Impact Delivered

    With Insight 360, the client achieved measurable results:

  • 75% increase in efficiency – reduced manual effort and faster turnaround time.
  • Customizable analysis – adaptable framework across any therapy area or indication.
  • 70% cost savings – through deployment of fine-tuned AI models.
    • 5

    Why Insight 360?

    By combining real-time monitoring, AI powered analytics, and medical-scientific context, Insight 360 empowers pharma teams to:

  • Capture the unfiltered voice of HCPs and patients.
  • Identify gaps in awareness, education, and evidence.
  • Shape smarter, more targeted go-to-market strategies.
    • 1

    Business Challenge

    The client wanted to analyze social media activity across three major hematology congresses — ASCO, EHA, and ICML — with a focus on the hematology track.

    Key objectives:
    • Assess HCP sentiment and engagement around:
      • Bispecifics
      • Trispecifics
      • Antibody-Drug Conjugates (ADCs)
      • Menin Inhibitors
    • Understand whether HCP reactions aligned with internal expectations.
    • Identify gaps, concerns, or areas needing clarification.
    • Quantify the company’s scientific share of voice within the broader hematology conversation.
    2

    Insight 360 Approach

    To meet these objectives, Insight 360 deployed a structured AI-enabled analytics framework:
  • Data Curation: Aggregated public content from six major platforms using targeted congress- and therapy-specific keywords.
  • Entity Mapping: Applied NLP to extract and track mentions of studies, products, companies, and indications.
  • HCP & DOL Identification: Classified verified HCPs and mapped emerging digital opinion leaders (DOLs).
  • Thematic & Sentiment Analysis: Identified discussion trends and assessed sentiment intensity across themes.
  • Content Summarization: Generated concise summaries of high-volume discussions for actionable insights.
    • 3

    Key Findings & Recommendations

  • Collected 9K+ posts and videos from six distinct platforms.
  • Identified 11K+ unique HCPs engaging with hematology topics.
  • Found that most HCP activity involved retweeting/resharing, highlighting amplification and enthusiasm for key announcements.
  • Detected notable DOL activity on Bluesky, suggesting a potential migration trend away from Twitter/X in some HCP segments.
  • Observed that discussions on bispecifics and trispecifics were largely driven by Company X’s pipeline data in Multiple Myeloma and Lymphoma, confirming the company’s strong positioning and visibility.
    • 4

    Impact Delivered

  • 75% efficiency gain – reduced manual effort with faster insights delivery.
  • Scalability – adaptable framework for congress coverage across therapy areas.
  • 70% cost savings – achieved through optimized AI models.
    • 5

    Why Insight 360?

    With AI-powered analytics, scientific integration, and real-time tracking, Insight 360 empowers life sciences companies to:

  • Capture authentic HCP sentiment across congresses.
  • Monitor scientific share of voice in real time.
  • Detect emerging platforms and influencers early.
  • Align congress strategies with data-driven evidence.
    • 1

    Business Challenge

    Pharma teams struggled with fragmented data and outdated methods to track Healthcare Professionals (HCPs). This meant missed rising stars, limited network visibility, and delayed brand insights—ultimately slowing engagement and impact.
    2

    Solution

    Our AI-powered HCP Network Platform transformed the way HCP ecosystems are understood by:
  • Unifying real-time data from social media, CRMs, publications, trials, and KOL databases
  • Using ML/NLP to profile, categorize, and geotag HCPs with confidence scoring
  • Ranking HCPs on social reach, scholarly activity, and influence signals
  • Detecting emerging voices beyond CRM lists to capture future leaders early
  • Tracking brand sentiment and ripple effect across networks
  • Mapping social, academic, and clinical ties to visualize influence clusters
    • 3

    Impact

  • 50% faster KOL discovery across therapeutic areas
  • Real-time network intelligence to uncover hidden influencers
  • Proactive risk management through sentiment-driven strategies
  • Smarter engagement powered by actionable, AI-driven insights
    • 1

    Business Challenge

    Prostate cancer care is inherently multidisciplinary, involving general physicians, urologists, oncologists, radiologists, psychologists, and patient support networks. Traditional methods of understanding this journey are siloed, focusing only on direct referrals or clinical data. This leaves gaps in understanding the true influence and interconnectedness of HCPs across treatment stages and support systems.
    2

    AI-Powered Solution

    Using our AI-driven HCP Network Intelligence , we mapped the entire prostate cancer journey:
  • AI-driven HCP Profiling: Identified urologists as pivotal nodes in the ecosystem using social media, CRM, publication, and trial data.
  • Multidimensional Categorization: Applied ML/NLP to classify HCPs by specialty (oncology, radiology, psychology) and setting (community vs academic).
  • Network Analysis: Leveraged AI-based graph analytics to map referrals, co publications, and online influence across social media (Twitter, LinkedIn, Bluesky, forums).
  • Sentiment & Influence Tracking: Assessed emotional tone from patient forums and HCP discussions; calculated ripple effect of key influencers.
  • Cross-Disciplinary Visualization: Revealed how urologists serve as central connectors between general physicians, oncologists, radiologists, psychologists, and patient support groups.
    • 3

    Impact

  • 360° HCP Ecosystem View: AI uncovered hidden influencers (e.g., community physicians, clinical psychologists) often overlooked in traditional mapping.
  • Smarter Targeting: Identified urologists and “rising stars” as priority engagement nodes for Medical Affairs.
  • Faster Insights: Reduced manual mapping time by >60%, enabling real-time monitoring of HCP interactions and patient support networks.
  • Enhanced Strategy: Empowered Medical and Commercial teams to design cross specialty engagement strategies aligned to patient journey touchpoints.
    • 4

    Outcome

    With AI, the client moved beyond static referral pathways to a living, dynamic map of HCP influence networks, delivering sharper engagement strategies, better patient support alignment, and early identification of multidisciplinary influencers across the prostate cancer journey.
    1

    Business Challenge

    Social media platforms like Twitter host millions of conversations from active healthcare professionals (HCPs), patient advocates, and thought leaders who continuously shape medical discourse. A leading pharmaceutical company needed to harness 15 years of social media data around a key brand and its trial.

    The challenge:
  • Track shifts in sentiment across the brand lifecycle
  • Understand the impact of major medical congresses
  • Monitor long-term engagement trends
  • Evaluate market and stakeholder response

    • The client required an approach that would provide real-time and longitudinal insights while minimizing manual effort.
    2

    How Insight 360 Solved It

    We deployed Insight 360, powered by advanced AI (Mistral, OpenAI, WatsonX) and NLP/ML capabilities, to transform fragmented social conversations into strategic intelligence.

    Key capabilities included:
  • Pattern Detection (Themes & Sentiment): AI identified engagement and sentiment shifts over time.
  • Topic Extraction: Captured competitor activity, trial discussions, and emerging themes.
  • User Identification: Segmented audiences into HCPs, patient advocacy groups, finance analysts, and digital opinion leaders.
  • Top List Creation: Generated ranked DOL lists using engagement metrics, reach, and influence scores.
  • Automated Reporting: Delivered curated insights directly to Medical Leadership for evidence-driven decision-making.
    • 3

    Outcomes Delivered

    1. Comprehensive 15-Year Tracking
      • a. Deep dive into sentiment share of voice (SOV) before and after launch
      • b. YOY engagement metrics and influencer shifts
      • c. Identification of top DOLs in the disease area with sentiment mapping
      • d. Actionable recommendations for:
        • i. Efficacy & safety management
        • ii. Evidence generation and transparency
        • iii. Targeted HCP engagement
    2. Efficiency at Scale
      • a. Automation cut manual analysis effort by 70%
      • b. Freed up resources to focus on insight activation and engagement strategy
    4

    Impact with Insight 360

    Insight 360 enabled the client to transform 15 years of fragmented conversations into a living knowledge base. By combining AI-powered sentiment tracking, influencer mapping, and longitudinal analysis, the platform delivered:
  • Sharper medical strategy with real-time evidence
  • Smarter HCP engagement through targeted outreach
  • Greater transparency and market alignment across the product lifecycle
    • 1

    Business Challenge

    A top pharmaceutical company preparing to launch a new asset faced familiar challenges in aligning medical strategy with execution:
  • Strategic imperatives (e.g., RWE generation, HCP education, biomarker strategy) were defined but not systematically linked to measurable objectives and tactics.
  • Multiple teams (Medical, Commercial, Access, Evidence) worked in silos, with fragmented plans in PPTs, Excel, and SharePoint.
  • Leadership struggled to track whether launch-critical activities were being executed against the Field Medical (FM) Plan, and whether they were delivering impact.
  • Manual reporting meant risks and gaps were only surfaced retrospectively—too late for effective course correction during the high-pressure launch window.
    • 2

    Solution: Medical 360 Platform

    The company deployed Medical 360 as the single source of truth for medical launch planning and execution.

    Within the platform:
  • Strategic Imperatives (SIs) & Medical Objectives (MOs): The team defined launch imperatives (e.g., generate RWE, educate HCPs, establish biomarker strategy) and broke them into measurable objectives.
  • Alignment Across Functions: Every activity was directly tied back to the medical plan, ensuring cross-functional teams (Medical, Evidence, Patient Engagement) worked from a unified framework.
  • Prioritization & Visibility: The platform highlighted how many objectives fed into each imperative, helping leadership focus resources on high-impact launch drivers.
  • Progress Tracking: Dashboards provided real-time visibility into execution status— whether congress activities, HCP education campaigns, or post-launch studies were on track.
  • Insight Loop: By capturing outcomes such as HCP reactions, data dissemination, and trial progress, Medical 360 allowed teams to pivot strategies mid launch to maximize impact.
    • 3

    Outcomes

  • Strategic Clarity: Clear line of sight from SIs → MOs → Tactics ensured every launch activity supported core medical strategy.
  • Faster Course Correction: Real-time progress tracking allowed gaps in RWE, HCP education, or evidence communication to be addressed quickly.
  • Cross-Functional Alignment: Medical, Commercial, and Access teams operated from a shared, integrated plan—reducing duplication and misalignment across affiliates.
  • Efficiency Gains: Manual PPT/Excel reporting was replaced with automated dashboards, cutting reporting time by >60%.
  • Leadership Confidence: Decision-makers gained visibility into whether Medical Affairs was delivering measurable impact during launch.
    • 4

    Impact with Medical 360

    Medical 360 enabled the client to transform launch planning from fragmented and reactive to integrated and impact-driven. By connecting strategy, objectives, and execution in a single platform, the company achieved sharper HCP engagement, more consistent global–local alignment, and measurable medical impact throughout the launch window. Launch excellence became not just a plan on paper, but a living, trackable framework that delivered actionable insights and accelerated decision-making.

    Business Challenge

    The client wanted to analyze social media activity across three major hematology congresses — ASCO, EHA, and ICML — with a focus on the hematology track.

    Key objectives:
  • Assess HCP sentiment and engagement around:
  • Bispecifics
  • Trispecifics
  • Antibody-Drug Conjugates (ADCs)
  • Menin Inhibitors
  • Understand whether HCP reactions aligned with internal expectations.
  • Identify gaps, concerns, or areas needing clarification.
  • Quantify the company’s scientific share of voice within the broader hematology conversation.

    • Insight 360 Approach

    To meet these objectives, Insight 360 deployed a structured AI-enabled analytics framework:
  • Data Curation: Aggregated public content from six major platforms using targeted congress- and therapy-specific keywords.
  • Entity Mapping: Applied NLP to extract and track mentions of studies, products, companies, and indications.
  • HCP & DOL Identification: Classified verified HCPs and mapped emerging digital opinion leaders (DOLs).
  • Thematic & Sentiment Analysis: Identified discussion trends and assessed sentiment intensity across themes.
  • Content Summarization: Generated concise summaries of high-volume discussions for actionable insights.

    • Key Findings & Recommendations

  • Collected 9K+ posts and videos from six distinct platforms.
  • Identified 11K+ unique HCPs engaging with hematology topics.
  • Found that most HCP activity involved retweeting/resharing, highlighting amplification and enthusiasm for key announcements.
  • Detected notable DOL activity on Bluesky, suggesting a potential migration trend away from Twitter/X in some HCP segments.
  • Observed that discussions on bispecifics and trispecifics were largely driven by Company X’s pipeline data in Multiple Myeloma and Lymphoma, confirming the company’s strong positioning and visibility.

    • Impact Delivered

  • 75% efficiency gain – reduced manual effort with faster insights delivery.
  • Scalability – adaptable framework for congress coverage across therapy areas.
  • 70% cost savings – achieved through optimized AI models.

    • Why Insight 360?

    With AI-powered analytics, scientific integration, and real-time tracking, Insight 360 empowers life sciences companies to:
  • Capture authentic HCP sentiment across congresses.
  • Monitor scientific share of voice in real time.
  • Detect emerging platforms and influencers early.
  • Align congress strategies with data-driven evidence.

    • A digital-first life sciences domain-centric consulting and technology engineering powerhouse solving complex problems for our clients.